Skip to main content
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · IEX Real-Time Price · USD
9.03
-0.07 (-0.77%)
Apr 26, 2024, 10:24 AM EDT - Market open

Elicio Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Elicio Therapeutics stock has a target of 11, which predicts an increase of 21.82% from the current stock price of 9.03.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change +21.82% +21.82% +21.82% +21.82%
* Price targets were last updated on Jan 17, 2024.

Analyst Ratings

The average analyst rating for ELTX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '24Feb '24Mar '24Apr '24
Strong Buy 1111
Buy 0000
Hold 0001
Sell 0000
Strong Sell 0000
Total 1112

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Matthew Biegler
Oppenheimer
 Oppenheimer
Hold
Reiterates
n/a
 Hold Reiterates n/a n/a Apr 1, 2024
Robert Burns
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Maintains
$10 → $11
 Strong Buy Maintains $10 → $11 +21.82% Jan 17, 2024
Robert Burns
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Initiates
$12
 Strong Buy Initiates $12 +32.89% Oct 26, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.55
from -6.96
EPS Next Year
-4.27
from -4.55
Year 20192020202120222023202420252026
Revenue
1.49M2.88M28.31M-----
Revenue Growth
-63.09%93.68%883.06%-----
EPS
-28.20-54.30-19.30-89.27-6.96-4.55-4.27-4.06
EPS Growth
--------
No. Analysts -----433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -4.68 -4.40 -4.18
Avg -4.55 -4.27 -4.06
Low -4.37 -4.11 -3.90

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.